Current advances of CRISPR-Cas technology in cell therapy

CRISPR-Cas is a versatile genome editing technology that has been broadly applied in both basic research and translation medicine. Ever since its discovery, the bacterial derived endonucleases have been engineered to a collection of robust genome-editing tools for introducing frameshift mutations or...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Hou-Yuan, Ji, Rui-Jin, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120314/
https://www.ncbi.nlm.nih.gov/pubmed/37193354
http://dx.doi.org/10.1016/j.cellin.2022.100067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120314/
https://www.ncbi.nlm.nih.gov/pubmed/37193354
http://dx.doi.org/10.1016/j.cellin.2022.100067

Ejemplares similares